Director, Competitive & Strategic Insights, Oncology Lead
abbvie
Umowa o pracęPełny etatOpublikowano 1 listopada 2026
Źródło: About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
The CSI Director drives insights at a global level (with a US focus) for pre-clinical to late clinical Oncology assets, providing an objective view of the competitive landscape and emerging trends. This individual will be a strategic partner to the asset strategy teams and influence the overall development of the assets or key mechanisms of interest.
Responsibilities include informing the clinical target product profile, supporting go/no go decisions, tracking safety & efficacy data of competitors, assessing evolution of the standard of care, understanding clinical timelines and competitor status. The CSI team supports key governance decisions at asset milestones and partners with BD and S&E. The individual in this role will have high visibility and opportunities to influence key decisions to support AbbVie’ Oncology pipeline.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
The CSI Director drives insights at a global level (with a US focus) for pre-clinical to late clinical Oncology assets, providing an objective view of the competitive landscape and emerging trends. This individual will be a strategic partner to the asset strategy teams and influence the overall development of the assets or key mechanisms of interest.
Responsibilities include informing the clinical target product profile, supporting go/no go decisions, tracking safety & efficacy data of competitors, assessing evolution of the standard of care, understanding clinical timelines and competitor status. The CSI team supports key governance decisions at asset milestones and partners with BD and S&E. The individual in this role will have high visibility and opportunities to influence key decisions to support AbbVie’ Oncology pipeline.
